참고문헌
- Batista, PJ, and Chang, HY (2013). Long noncoding RNAs: cellular address codes in development and disease. Cell. 152, 1298-1307. https://doi.org/10.1016/j.cell.2013.02.012
- Boyer, J, Allen, WL, McLean, EG, Wilson, PM, McCulla, A, Moore, S, Longley, DB, Caldas, C, and Johnston, PG (2006). Pharmacogenomic identification of novel determinants of response to chemotherapy in colon cancer. Cancer Res. 66, 2765-2777. https://doi.org/10.1158/0008-5472.CAN-05-2693
- Choi, CH, Lee, TB, Lee, YA, Choi, S, and Kim, KJ (2011). Upregulation of cyclooxygenase-2-derived prostaglandin E(2) in colon cancer cells resistant to 5-fluorouracil. J Korean Surg Soc. 81, 115-121. https://doi.org/10.4174/jkss.2011.81.2.115
- Djebali, S, Davis, CA, Merkel, A, Dobin, A, Lassmann, T, Mortazavi, A, Tanzer, A, Lagarde, J, Lin, W, and Schlesinger, F (2012). Landscape of transcription in human cells. Nature. 489, 101-108. https://doi.org/10.1038/nature11233
- Esteller, M (2011). Non-coding RNAs in human disease. Nat Rev Genet. 12, 861-874. https://doi.org/10.1038/nrg3074
- Fan, Y, Shen, B, Tan, M, Mu, X, Qin, Y, Zhang, F, and Liu, Y (2014). Long non-coding RNA UCA1 increases chemoresistances of bladder cancer cells by regulating Wnt signaling. FEBS J. 281, 1750-1758. https://doi.org/10.1111/febs.12737
- Fatica, A, and Bozzoni, I (2013). Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet. 15, 7-21. https://doi.org/10.1038/nrg3606
- Fojo, T (2007). Multiple paths to a drug resistance phenotype: mutations, translocations, deletions and amplification of coding genes or promoter regions, epigenetic changes and microRNAs. Drug Resist Updat. 10, 59-67. https://doi.org/10.1016/j.drup.2007.02.002
- Fulda, S, Susin, SA, Kroemer, G, and Debatin, KM (1998). Molecular ordering of apoptosis induced by anticancer drugs in neuroblastoma cells. Cancer Res. 58, 4453-4460.
- Ganguly, A, Banerjee, K, Chakraborty, P, Das, S, Sarkar, A, Hazra, A, Banerjee, M, Maity, A, Chatterjee, M, and Mondal, NB (2011). Overcoming multidrug resistance (MDR) in cancer in virto and in vivo by a quinoline derivative. Biomed Pharmacother. 65, 387-394. https://doi.org/10.1016/j.biopha.2011.04.024
- Gibb, EA, Brown, CJ, and Lam, WL (2011). The functional role of long non-coding RNA in human carcinomas. Mol Cancer. 10, 38. https://doi.org/10.1186/1476-4598-10-38
- Glasspool, RM, Teodoridis, JM, and Brown, R (2006). Epigenetics as a mechanism driving polygenic clinical drug resistance. Br J Cancer. 94, 1087-1092. https://doi.org/10.1038/sj.bjc.6603024
- Gottesman, MM (2002). Mechanisms of cancer drug resistance. Ann Rev Med. 53, 615-627. https://doi.org/10.1146/annurev.med.53.082901.103929
- Grem, JL (2000). 5-Fluorouracil: forty-plus and still ticking. A review of its preclinical and clinical development. Invest New Drugs. 18, 299-313. https://doi.org/10.1023/A:1006416410198
- International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators (1995). Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet. 345, 939-944. https://doi.org/10.1016/S0140-6736(95)90696-7
- Jung, GR, Kim, KJ, Choi, CH, Lee, TB, Han, SI, Han, HK, and Lim, SC (2007). Effect of betulinic acid on anticancer drug-resistant colon cancer cells. Basic Clin Pharmacol Toxicol. 101, 277-285. https://doi.org/10.1111/j.1742-7843.2007.00115.x
- Kang, H, Kim, C, Lee, H, Kim, W, and Lee, EK (2013). Post-transcriptional controls by ribonucleoprotein complexes in the acquisition of drug resistance. Int J Mol Sci. 14, 17204-17220. https://doi.org/10.3390/ijms140817204
- Karasawa, H, Miura, K, Fujibuchi, W, Ishida, K, Kaneko, N, Kinouchi, M, Okabe, M, Ando, T, Murata, Y, and Sasaki, H (2009). Down-regulation of cIAP2 enhances 5-FU sensitivity through the apoptotic pathway in human colon cancer cells. Cancer Sci. 100, 903-913. https://doi.org/10.1111/j.1349-7006.2009.01112.x
- Kurokawa, K, Tanahashi, T, Iima, T, Yamamoto, Y, Akaike, Y, Nishida, K, Masuda, K, Kuwano, Y, Murakami, Y, and Fukushima, M (2012). Role of miR-19b and its target mRNAs in 5-fluorouracil resistance in colon cancer cells. J Gastroenterol. 47, 883-895. https://doi.org/10.1007/s00535-012-0547-6
- Liu, Z, Sun, M, Lu, K, Liu, J, Zhang, M, Wu, W, De, W, Wang, Z, and Wang, R (2013). The long noncoding RNA HOTAIR contributes to cisplatin resistance of human lung adenocarcinoma cells via downregualtion of p21(WAF1/CIP1) expression. PLoS One. 8, e77293. https://doi.org/10.1371/journal.pone.0077293
- Ma, J, Dong, C, and Ji, C (2010). MicroRNA and drug resistance. Cancer Gene Ther. 17, 523-531. https://doi.org/10.1038/cgt.2010.18
- Mariadason, JM, Arango, D, Shi, Q, Wilson, AJ, Corner, GA, Nicholas, C, Aranes, MJ, Lesser, M, Schwartz, EL, and Augenlicht, LH (2003). Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin. Cancer Res. 63, 8791-8812.
- Mercer, TR, Dinger, ME, and Mattick, JS (2009). Long non-coding RNAs: insights into functions. Nat Rev Genet. 10, 155-159. https://doi.org/10.1038/nrg2521
- Mishra, PJ (2012). The miRNA-drug resistance connection: a new era of personalized medicine using noncoding RNA begins. Pharmacogenomics. 13, 1321-1324. https://doi.org/10.2217/pgs.12.121
- Mishra, PJ, and Bertino, JR (2009). MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine. Pharmacogenomics. 10, 399-416. https://doi.org/10.2217/14622416.10.3.399
- Oh, JH, Ku, JL, Yoon, KA, Kwon, HJ, Kim, WH, Park, HS, Yeo, KS, Song, SY, Chung, JK, and Park, JG (1999). Establishment and characterization of 12 human colorectal-carcinoma cell lines. International journal of cancer. J Int Cancer. 81, 902-910. https://doi.org/10.1002/(SICI)1097-0215(19990611)81:6<902::AID-IJC11>3.0.CO;2-T
- Ooyama, A, Takechi, T, Toda, E, Nagase, H, Okayama, Y, Kitazato, K, Sugimoto, Y, Oka, T, and Fukushima, M (2006). Gene expression analysis using human cancer xenografts to identify novel predictive marker genes for the efficacy of 5-fluorouracil-based drugs. Cancer Sci. 97, 510-522. https://doi.org/10.1111/j.1349-7006.2006.00204.x
- Park, JG, Oie, HK, Sugarbaker, PH, Henslee, JG, Chen, TR, Johnson, BE, and Gazdar, A (1987). Characteristics of cell lines established from human colorectal carcinoma. Cancer Res. 47, 6710-6718.
- Parrott, AM, and Mathews, MB (2007). Novel rapidly evolving hominid RNAs bind nuclear factor 90 and display tissue-restricted distribution. Nucleic Acids Res. 35, 6249-6258. https://doi.org/10.1093/nar/gkm668
- Parrott, AM, and Mathews, MB (2009). snaR genes: recent descendants of Alu involved in the evolution of chorionic gonadotropins. Cold Spring Harbor Symp Quant Biol. 74, 363-373. https://doi.org/10.1101/sqb.2009.74.038
- Parrott, AM, Tsai, M, Batchu, P, Ryan, K, Ozer, HL, Tian, B, and Mathews, MB (2011). The evolution and expression of the snaR family of small non-coding RNAs. Nucleic Acids Res. 39, 1485-1500. https://doi.org/10.1093/nar/gkq856
- Peters, GJ, Backus, HH, Freemantle, S, van Triest, B, Codacci-Pisanelli, G, van der Wilt, CL, Smid, K, Lunec, J, Calvert, AH, and Marsh, S (2002). Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism. Biochim Biophys Acta. 1587, 194-205. https://doi.org/10.1016/S0925-4439(02)00082-0
- Raguz, S, and Yague, E (2008). Resistance to chemotherapy: new treatments and novel insights into an old problem. Br J Cancer. 99, 387-391. https://doi.org/10.1038/sj.bjc.6604510
- Rinn, JL, and Chang, HY (2012). Genome regulation by long noncoding RNAs. Ann Rev Biochem. 81, 145-166. https://doi.org/10.1146/annurev-biochem-051410-092902
- Roberti, A, La Sala, D, and Cinti, C (2006). Multiple genetic and epigenetic interacting mechanisms contribute to clonally selection of drug-resistant tumors: current views and new therapeutic prospective. J Cell Physiol. 207, 571-581. https://doi.org/10.1002/jcp.20515
- Rukov, JL, and Shomron, N (2011). MicroRNA pharmacogenomics: post-transcriptional regulation of drug response. Trends Mol Med. 17, 412-423. https://doi.org/10.1016/j.molmed.2011.04.003
- Shin, YK, Yoo, BC, Chang, HJ, Jeon, E, Hong, SH, Jung, MS, Lim, SJ, and Park, JG (2005). Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance. Cancer Res. 65, 3162-3170.
- Shin, YK, Yoo, BC, Hong, YS, Chang, HJ, Jung, KH, Jeong, SY, and Park, JG (2009). Upregulation of glycolytic enzymes in proteins secreted from human colon cancer cells with 5-fluorouracil resistance. Electrophoresis. 30, 2182-2192. https://doi.org/10.1002/elps.200800806
- Strathdee, G (2007). Epigenetic markers and response to chemotherapy in cancer. Dis Markers. 23, 43-49. https://doi.org/10.1155/2007/610815
- Taft, RJ, Pang, KC, Mercer, TR, Dinger, M, and Mattick, JS (2010). Non-coding RNAs: regulators of disease. J Pathol. 220, 126-139. https://doi.org/10.1002/path.2638
- Tan, DS, Gerlinger, M, Teh, BT, and Swanton, C (2010). Anticancer drug resistance: understanding the mechanisms through the use of integrative genomics and functional RNA interference. Eur J Cancer. 46, 2166-2177. https://doi.org/10.1016/j.ejca.2010.03.019
- Wang, KC, and Chang, HY (2011). Molecular mechanisms of long noncoding RNAs. Mol Cell. 43, 904-914. https://doi.org/10.1016/j.molcel.2011.08.018
- Wang, Z, Li, Y, Ahmad, A, Azmi, AS, Kong, D, Banerjee, S, and Sarkar, FH (2010). Targeting miRNAs involved in cancer stem cell and EMT regulation: an emerging concept in overcoming drug resistance. Drug Resist Updat. 13, 109-118. https://doi.org/10.1016/j.drup.2010.07.001
- Whitehead, J, Pandey, GK, and Kanduri, C (2009). Regulation of the mammalian epigenome by long noncoding RNAs. Biochim Biophys Acta. 1790, 936-947. https://doi.org/10.1016/j.bbagen.2008.10.007
- Wilusz, JE, Sunwoo, H, and Spector, DL (2009). Long noncoding RNAs: functional surprises from the RNA world. Genes Dev. 23, 1494-1504. https://doi.org/10.1101/gad.1800909
- Xu, X, Chen, H, Lin, Y, Hu, Z, Mao, Y, Wu, J, Xu, X, Zhu, Y, Li, S, and Zheng, X (2013). MicroRNA-409-3p inhibits migration and invasion of bladder cancer cells via targeting c-Met. Mol Cells. 36, 62-68. https://doi.org/10.1007/s10059-013-0044-7
- Zhang, N, Yin, Y, Xu, SJ, and Chen, WS (2008). 5-Fluorouracil: mechanisms of resistance and reversal strategies. Molecules. 13, 1551-1569. https://doi.org/10.3390/molecules13081551
- Zheng, T, Wang, J, Chen, X, and Liu, L (2010). Role of micro-RNA in anticancer drug resistance. Int J Cancer. 126, 2-10. https://doi.org/10.1002/ijc.24782
피인용 문헌
- Emerging role of long noncoding RNAs in lung cancer: Current status and future prospects vol.110, 2016, https://doi.org/10.1016/j.rmed.2015.10.006
- Roles and expression profiles of long non-coding RNAs in triple-negative breast cancers 2017, https://doi.org/10.1111/jcmm.13327
- The Mechanism and Function of Epigenetics in Uterine Leiomyoma Development vol.23, pp.2, 2016, https://doi.org/10.1177/1933719115584449
- Role of long non-coding RNA in tumor drug resistance vol.37, pp.9, 2016, https://doi.org/10.1007/s13277-016-5125-8
- Long Noncoding RNAs in Digestive System Malignancies: A Novel Class of Cancer Biomarkers and Therapeutic Targets? vol.2015, 2015, https://doi.org/10.1155/2015/319861
- Long Non-coding RNAs and Drug Resistance vol.16, pp.18, 2015, https://doi.org/10.7314/APJCP.2015.16.18.8067
- Exploration of Deregulated Long Non-Coding RNAs in Association with Hepatocarcinogenesis and Survival vol.7, pp.3, 2015, https://doi.org/10.3390/cancers7030865
- Long non-coding RNA UCA1 promotes cisplatin/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells vol.382, pp.1, 2016, https://doi.org/10.1016/j.canlet.2016.08.015
- Non-coding landscapes of colorectal cancer vol.21, pp.41, 2015, https://doi.org/10.3748/wjg.v21.i41.11709
- Insights into the involvement of noncoding RNAs in 5-fluorouracil drug resistance vol.39, pp.4, 2017, https://doi.org/10.1177/1010428317697553
- Colorectal Cancer: From the Genetic Model to Posttranscriptional Regulation by Noncoding RNAs vol.2017, 2017, https://doi.org/10.1155/2017/7354260
- Microarray expression profile of long non-coding RNAs in paclitaxel-resistant human lung adenocarcinoma cells vol.38, pp.1, 2017, https://doi.org/10.3892/or.2017.5691
- miR-20b reduces 5-FU resistance by suppressing the ADAM9/EGFR signaling pathway in colon cancer vol.37, pp.1, 2017, https://doi.org/10.3892/or.2016.5259
- lncRNA UCA1 Contributes to Imatinib Resistance by Acting as a ceRNA Against miR-16 in Chronic Myeloid Leukemia Cells vol.36, pp.1, 2017, https://doi.org/10.1089/dna.2016.3533
- Long Non-Coding RNA lincRNA-ROR Promotes the Progression of Colon Cancer and Holds Prognostic Value by Associating with miR-145 vol.22, pp.4, 2016, https://doi.org/10.1007/s12253-016-0061-x
- Microarray Analysis of Long Non-coding RNA Expression Profile Associated with 5-Fluorouracil-Based Chemoradiation Resistance in Colorectal Cancer Cells vol.16, pp.8, 2015, https://doi.org/10.7314/APJCP.2015.16.8.3395
- Expression profile analysis of long non-coding RNA associated with vincristine resistance in colon cancer cells by next-generation sequencing vol.572, pp.1, 2015, https://doi.org/10.1016/j.gene.2015.06.087
- Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance vol.8, pp.3, 2017, https://doi.org/10.3390/genes8030095
- Long non-coding RNAs in cancer drug resistance development vol.45, 2016, https://doi.org/10.1016/j.dnarep.2016.06.003
- Long non-coding ribonucleic acid zinc finger antisense 1 promotes the progression of colonic cancer by modulating ZEB1 expression vol.32, pp.6, 2017, https://doi.org/10.1111/jgh.13646
- Linc00659, a long noncoding RNA, acts as novel oncogene in regulating cancer cell growth in colorectal cancer vol.17, pp.1, 2018, https://doi.org/10.1186/s12943-018-0821-1
- Down-regulation of lncRNA snaR is correlated with postoperative distant recurrence of HPV-negative cervical squamous cell carcinoma vol.38, pp.6, 2018, https://doi.org/10.1042/BSR20181213
- The Network of Non-coding RNAs in Cancer Drug Resistance vol.8, pp.2234-943X, 2018, https://doi.org/10.3389/fonc.2018.00327
- Expression analysis of beta-secretase 1 (BACE1) and its naturally occurring antisense (BACE1-AS) in blood of epileptic patients vol.39, pp.9, 2018, https://doi.org/10.1007/s10072-018-3458-3
- pp.13479032, 2019, https://doi.org/10.1111/cas.13951
- Long non-coding RNAs in anti-cancer drug resistance vol.8, pp.1, 2014, https://doi.org/10.18632/oncotarget.12461
- Silence of long noncoding RNA PANDAR switches low-dose curcumin-induced senescence to apoptosis in colorectal cancer cells vol.10, pp.None, 2014, https://doi.org/10.2147/ott.s127547
- Knockdown of lncRNA-XIST enhances the chemosensitivity of NSCLC cells via suppression of autophagy vol.38, pp.6, 2017, https://doi.org/10.3892/or.2017.6056
- Long non-coding RNAs: a rising biotarget in colorectal cancer vol.8, pp.13, 2014, https://doi.org/10.18632/oncotarget.14728
- lncRNA Expression after Irradiation and Chemoexposure of HNSCC Cell Lines vol.4, pp.4, 2018, https://doi.org/10.3390/ncrna4040033
- LncRNAs as Regulators of Autophagy and Drug Resistance in Colorectal Cancer vol.9, pp.None, 2014, https://doi.org/10.3389/fonc.2019.01008
- LncRNAs with miRNAs in regulation of gastric, liver, and colorectal cancers: updates in recent years vol.103, pp.12, 2014, https://doi.org/10.1007/s00253-019-09837-5
- Diagnostic and prognostic potential of tissue and circulating long non-coding RNAs in colorectal tumors vol.25, pp.34, 2014, https://doi.org/10.3748/wjg.v25.i34.5026
- ncRNAs associated with drug resistance and the therapy of digestive system neoplasms vol.234, pp.11, 2014, https://doi.org/10.1002/jcp.28551
- The emerging role of noncoding RNAs in colorectal cancer chemoresistance vol.42, pp.6, 2014, https://doi.org/10.1007/s13402-019-00466-8
- Long non-coding RNAs as a determinant of cancer drug resistance: Towards the overcoming of chemoresistance via modulation of lncRNAs vol.50, pp.None, 2014, https://doi.org/10.1016/j.drup.2020.100683
- Emerging role of long non-coding RNAs in cancer chemoresistance: unravelling the multifaceted role and prospective therapeutic targeting vol.47, pp.7, 2014, https://doi.org/10.1007/s11033-020-05609-x
- Lincp21-RNA as Predictive Response Marker for Preoperative Chemoradiotherapy in Rectal Cancer vol.11, pp.5, 2021, https://doi.org/10.3390/jpm11050420
- A noncanonical microRNA derived from the snaR-A noncoding RNA targets a metastasis inhibitor vol.27, pp.6, 2014, https://doi.org/10.1261/rna.078694.121